The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Visa Inc. (V) ...

Lastly, its wholly owned subsidiary, Corellia, has its own AI drug discovery unit that uses its own dataset to produce drugs.

Vivo could soon unveil its first FE-branded smartphone in the X200 series. The X200 FE has already been spotted on Bluetooth SIG and India’s BIS certification websites. Now, a new report by ...

INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

Fans of vivo smartphones are in for a treat. We’ve rounded up the best vivo mobile phones that offer top-notch features, premium build quality, and excellent performance. Whether you’re ...

They are utilised for an increasing number of commercial advanced therapy technologies, from chimeric antigen receptor (CAR) T-cell therapies to ex vivo gene therapies and, earlier last year ...

The Vivo Y300 5G features a 6.67-inch (2400 ×1080 pixels) Full HD+ E4 AMOLED screen with a 120Hz refresh rate. It is powered by the Snapdragon 4 Gen 2 processor paired with 8GB RAM and up to ...

Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it to build on its foundational insights into precision in vivo engineering ...

Vivo T4 5G will likely be powered by a MediaTek Dimensity 6300 chipset The handset is expected to be priced around Rs. 10,000 in India The Vivo T4 5G series may include a Pro variant soon ...

Vivo X200 FE is rumoured to launch as a compact smartphone A phone with model number V2503 had previously appeared on the BIS site Vivo X200 FE could be a rebrand of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...